Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Provectus Pharmaceuticals (PVCT) just unveiled an announcement.
Bruce Horowitz has stepped down from his roles at Provectus Biopharmaceuticals, including his position on the Board and as Chief Operating Officer. A termination agreement was reached, wherein Horowitz will receive a total payment of $508,000 if paid by June 30, 2024, and he has agreed to a five-year standstill on company securities. Following his departure, the company has appointed Dominic Rodrigues as the chief operations consultant and principal executive officer. Rodrigues brings a wealth of experience from various industries and academia, and will receive a monthly payment of $20,000 for his services, with the contract operating on a month-to-month basis.
For an in-depth examination of PVCT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- RTO Doesn’t Always Mean RTO: Microsoft Stock (NASDAQ:MSFT) Notches Up as Salespeople Find Exemption
- This Was Not the First Bid: Warner Bros. Discovery Stock (NASDAQ:WBD) Gains as it Rejected Three Bids from Paramount So Far
- ‘Paramount Can Walk Away with Warner Bros.’ Say TD Cowen and Benchmark Analysts